BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30393159)

  • 1. Loss of TMEM126A promotes extracellular matrix remodeling, epithelial-to-mesenchymal transition, and breast cancer metastasis by regulating mitochondrial retrograde signaling.
    Sun HF; Yang XL; Zhao Y; Tian Q; Chen MT; Zhao YY; Jin W
    Cancer Lett; 2019 Jan; 440-441():189-201. PubMed ID: 30393159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment.
    Dinca SC; Greiner D; Weidenfeld K; Bond L; Barkan D; Jorcyk CL
    Breast Cancer Res; 2021 May; 23(1):56. PubMed ID: 34011405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
    M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
    Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
    Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.
    Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C
    Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex.
    Fattet L; Jung HY; Matsumoto MW; Aubol BE; Kumar A; Adams JA; Chen AC; Sah RL; Engler AJ; Pasquale EB; Yang J
    Dev Cell; 2020 Aug; 54(3):302-316.e7. PubMed ID: 32574556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of CFTR promotes epithelial-to-mesenchymal transition and is associated with poor prognosis of breast cancer.
    Zhang JT; Jiang XH; Xie C; Cheng H; Da Dong J; Wang Y; Fok KL; Zhang XH; Sun TT; Tsang LL; Chen H; Sun XJ; Chung YW; Cai ZM; Jiang WG; Chan HC
    Biochim Biophys Acta; 2013 Dec; 1833(12):2961-2969. PubMed ID: 23916755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of motor protein KIF3C expression inhibits tumor growth and metastasis in breast cancer by inhibiting TGF-β signaling.
    Wang C; Wang C; Wei Z; Li Y; Wang W; Li X; Zhao J; Zhou X; Qu X; Xiang F
    Cancer Lett; 2015 Nov; 368(1):105-114. PubMed ID: 26272184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.
    Kuang J; Li L; Guo L; Su Y; Wang Y; Xu Y; Wang X; Meng S; Lei L; Xu L; Shao G
    J Exp Clin Cancer Res; 2016 Jun; 35(1):88. PubMed ID: 27259701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
    Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
    J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS-activated cancer cells.
    Mori K; Uchida T; Yoshie T; Mizote Y; Ishikawa F; Katsuyama M; Shibanuma M
    FEBS J; 2019 Feb; 286(3):459-478. PubMed ID: 30281903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular matrix density promotes EMT by weakening cell-cell adhesions.
    Kumar S; Das A; Sen S
    Mol Biosyst; 2014 Apr; 10(4):838-50. PubMed ID: 24481128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.
    Luo M; Hou L; Li J; Shao S; Huang S; Meng D; Liu L; Feng L; Xia P; Qin T; Zhao X
    Cancer Lett; 2016 Apr; 373(1):1-11. PubMed ID: 26805761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM12 induction by Twist1 promotes tumor invasion and metastasis via regulation of invadopodia and focal adhesions.
    Eckert MA; Santiago-Medina M; Lwin TM; Kim J; Courtneidge SA; Yang J
    J Cell Sci; 2017 Jun; 130(12):2036-2048. PubMed ID: 28468988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-373 drives the epithelial-to-mesenchymal transition and metastasis via the miR-373-TXNIP-HIF1α-TWIST signaling axis in breast cancer.
    Chen D; Dang BL; Huang JZ; Chen M; Wu D; Xu ML; Li R; Yan GR
    Oncotarget; 2015 Oct; 6(32):32701-12. PubMed ID: 26196741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.
    Ji S; Zhang W; Zhang X; Hao C; Hao A; Gao Q; Zhang H; Sun J; Hao J
    Oncotarget; 2016 Aug; 7(31):49411-49424. PubMed ID: 27384482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin promotes epithelial-mesenchymal transition of breast cancer via the upregulation of pyruvate kinase M2.
    Wei L; Li K; Pang X; Guo B; Su M; Huang Y; Wang N; Ji F; Zhong C; Yang J; Zhang Z; Jiang Y; Liu Y; Chen T
    J Exp Clin Cancer Res; 2016 Oct; 35(1):166. PubMed ID: 27769315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
    Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
    Sangaletti S; Tripodo C; Santangelo A; Castioni N; Portararo P; Gulino A; Botti L; Parenza M; Cappetti B; Orlandi R; Tagliabue E; Chiodoni C; Colombo MP
    Cell Rep; 2016 Sep; 17(1):233-248. PubMed ID: 27681434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.